Press

Conrad J. Heilman to Succeed Joseph S. Tempio as President and CEO of Tunnell Consulting

November 13, 2008

KING OF PRUSSIA, PA, NOVEMBER 13, 2008 --- The Board of Directors of Tunnell Consulting, Inc. today announced that Conrad J. Heilman, Ph.D., will succeed Joseph S. Tempio, Ph.D. as President and Chief Executive Officer, effective July 2009. Heilman will serve immediately as Chief Operating Officer and retain that post until he becomes President and CEO.

Heilman currently serves as Senior Vice President of the Life Sciences Strategic Operating Unit (SOU) with responsibility for the entire SOU including the firm’s offices in King of Prussia, California, and Puerto Rico. Since joining the firm in 2000 as a Managing Consultant, he has played an increasingly important role. He spearheaded multi-million dollar projects for respected international firms and partnered with key clients to develop and implement initiatives to improve operational performance and regulatory compliance. Heilman was instrumental in securing a contract with the National Institutes of Health (NIH) and a five-year $32 million dollar contract with the Department of Health and Human Services (HHS) to support the federal government’s pandemic flu preparedness initiative.

“Conrad has had a tremendous impact on Tunnell and has done an excellent job of building our Life Sciences Strategic Operating Unit. His vision and willingness to take risks has extended our reach into the public sector with his initial involvement with HHS,” said Tempio, who will continue as Chairman and will work closely with Heilman to ensure a smooth transition to President and CEO. “Conrad is a natural leader whose accomplishments in research, development, manufacturing, and regulatory issues make him ideally suited to managing Tunnell. The Board is confident that he will do a superb job in representing the firm to its clients and in providing them with exemplary service and innovative solutions to their most complex problems.”

Prior to Tunnell, Heilman held senior positions in a number of companies. He was President of Quality Biotech Inc., Vice President of Research for Pro-Virus, a Director of Applied Biotechnology at DuPont Merck Pharmaceutical Co., and held other managerial and research positions for E.I. DuPont De Nemours, American Cyanamid, and Litton Bionetics.

Heilman’s educational background in life sciences is extensive. A graduate of Long Island University with a B.S. degree in Biology, he earned his M.S. degree in Immunology from the University of Pennsylvania, and a Ph.D. in Pathobiology from Johns Hopkins University. He has published numerous articles in peer-reviewed journals and has a number of issued patents.

“Joe Tempio has guided the firm through one of its greatest growth periods and nurtured an environment that has driven profitability,” Heilman said.
In 1999 Tempio joined Tunnell as head of a new practice - Life Sciences Technical Services. Under his direction, the unit experienced a steady and healthy growth, and in 2004 Tunnell adopted a new strategy to focus on consulting exclusively in life sciences. To spur more growth, Tempio restructured the organization into three strategic operating units. One of the units he established was a Government Services operating unit with offices in Bethesda. Md.- which serves the life sciences segments of the federal government. In 2006, Tempio expanded operations by opening offices in San Diego and San Juan, Puerto Rico to better serve the unique needs of the life sciences community. Between 2004 - the year Tempio was appointed President and CEO – and 2008, Tunnell expects revenues will have increased by almost 100 percent.

“It is with great honor, excitement, and enthusiasm that I take on this new role and responsibilities of leading Tunnell as it moves forward to a new phase of growth and development,” said Heilman. “As we continue to grow and expand in other areas, we also realize that the life sciences industry is at a crossroads, with unprecedented changes. With increased competition among pharmaceutical companies, soaring health care costs, safety and patient issues, the climate is challenging but also offers exciting opportunities for the firm. With our depth of experience and focus in the life sciences, Tunnell is uniquely positioned to respond and adapt to the changing environment and help our clients solve their most complex problems.”

About Tunnell Consulting

Founded in 1962 and serving many of the world’s leading life sciences firms and government agencies, Tunnell Consulting, Inc. integrates strategic, technical and regulatory compliance skills to design and implement sustainable solutions that exactly meet client needs. With deep industry knowledge, extensive scientific and compliance credentials, and superior measurable results, we consistently boost the operating performance of each unique client we serve.

Return To Press

Printer Friendly